Financial Ratios

ASPIRA PATHLAB & DIAGNOSTICS LTD.

NSE : NABSE : 540788ISIN CODE : INE500C01017Industry : Hospital & Healthcare ServicesHouse : Private
BSE31.00-0.98 (-3.06 %)
PREV CLOSE ( ) 31.98
OPEN PRICE ( ) 34.75
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 1795
TODAY'S LOW / HIGH ( )30.20 34.89
52 WK LOW / HIGH ( ) 22.7649.5
NSE
This Company is not listed in NSE
Select year
ParticularsMar2023Mar2022Mar2021Mar2020Mar2019
Operational & Financial Ratios
   Earnings Per Share (Rs)-0.094.331.34-4.56-6.33
   CEPS(Rs)1.455.922.75-2.78-4.83
   DPS(Rs)0.000.000.000.000.00
   Book NAV/Share(Rs)12.3912.438.084.096.34
   Tax Rate(%)0.000.000.00-0.690.00
Margin Ratios
   Core EBITDA Margin(%)11.0232.3223.11-21.72-42.52
   EBIT Margin(%)2.2724.7314.95-38.02-55.28
   Pre Tax Margin(%)-0.6122.829.08-50.04-67.86
   PAT Margin (%)-0.6122.829.08-50.38-67.86
   Cash Profit Margin (%)10.3531.1918.58-30.66-51.78
Performance Ratios
   ROA(%)-0.5029.8210.58-29.11-37.93
   ROE(%)-0.6942.2622.80-94.32-187.57
   ROCE(%)2.4041.6321.52-26.30-34.50
   Asset Turnover(x)0.811.311.160.580.56
   Sales/Fixed Asset(x)0.861.291.160.690.74
   Working Capital/Sales(x)3.383.658.14-4.59-4.00
Efficiency Ratios
   Fixed Capital/Sales(x)1.170.770.871.451.35
   Receivable days86.2257.8427.6930.3727.50
   Inventory Days10.147.207.7212.0715.52
   Payable days69.7674.1273.8663.2841.68
Valuation Parameters
   PER(x)0.0014.9621.240.000.00
   PCE(x)19.1510.9410.38-13.79-5.67
   Price/Book(x)2.255.223.539.364.32
   Yield(%)0.000.000.000.000.00
   EV/Net Sales(x)1.893.371.935.023.92
   EV/Core EBITDA(x)14.2510.197.91-27.44-9.99
   EV/EBIT(x)83.0413.6412.94-13.20-7.08
   EV/CE(x)1.573.632.502.952.02
   M Cap / Sales1.983.411.934.232.93
Growth Ratio
   Net Sales Growth(%)-26.0228.5280.6610.2075.25
   Core EBITDA Growth(%)-70.4174.00341.4248.5718.04
   EBIT Growth(%)-93.20112.63171.0124.2111.62
   PAT Growth(%)-101.99222.91132.5718.187.15
   EPS Growth(%)-101.99222.91129.4027.8741.15
Financial Stability Ratios
   Total Debt/Equity(x)0.080.070.152.041.46
   Current Ratio(x)3.703.991.930.640.55
   Quick Ratio(x)3.443.771.750.590.48
   Interest Cover(x)0.7912.972.55-3.16-4.39
   Total Debt/Mcap(x)0.030.010.040.220.34

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X

(Note - You will receive a call from our sales executive)

CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.